Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population
Viral Immunology · 2024-05 · 37 (4) · 186-193
DOI: 10.1089/vim.2024.0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, online erschienen am 06.05.2024. Verfasst von Sara M Elessawy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: COVID-19, Membrane Proteins, RNA-Binding Proteins, SARS-CoV-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) represented an international health risk. Variants of the interferon-induced transmembrane protein-3 ( IFITM3 ) gene can increase the risk of developing severe viral infections. This cross-sectional study investigated the association between IFITM3 rs12252A>G single nucleotide polymorphism (SNP) and COVID-19 severity and mortality in 100 Egyptian patients. All participants were subjected to serum interleukin-6 (IL-6) determination by ELISA and IFITM3 rs12252 genotyping by real-time polymerase chain reaction. Of all participants, 85.0% had the IFITM3 rs12252 homozygous AA genotype, whereas 15.0% had the heterozygous AG genotype. None of our participants had the homozygous GG genotype. The IFITM3 rs12252A allele was found in 92.5% and the G allele in only 7.5%. There was no significant association ( p > 0.05) between the IFITM3 rs12252 SNP and COVID-19 severity, intensive care unit (ICU) admission, or IL-6 serum levels. The heterozygous AG genotype frequency showed a significant increase among participants who died (32.0%) compared with those who had been cured (9.3%). The mutant G allele was associated with patients' death. Its frequency among cured participants was 8.5%, whereas in those who died was 24.2% ( p = 0.024) with 3.429 odds ratio [95% confidence interval: 1.1–10.4]. In conclusion, this study revealed a significant association between the G allele variant of IFITM3 rs12252 and COVID-19 mortality. However, results were unable to establish a significant link between rs12252 polymorphism, disease severity, ICU admission, or serum IL-6 levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
ORCID-Profile: Sara I Taha
Zitieren
APA
Elessawy, S. M., Shehab, A., Soliman, D. A., Eldeeb, M. A., & Taha, S. I. (2024). Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population. Viral Immunology, 37(4), 186-193. https://doi.org/10.1089/vim.2024.0015
Vancouver
Elessawy SM, Shehab A, Soliman DA, Eldeeb MA, Taha SI. Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population. Viral Immunology. 2024;37(4):186-193. doi:10.1089/vim.2024.0015
BibTeX
@article{Elessawy2024,
author = {Elessawy, Sara M and Shehab, Abeer and Soliman, Dina A and Eldeeb, Mai A and Taha, Sara I},
title = {Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population},
journal = {Viral Immunology},
year = {2024},
volume = {37},
number = {4},
pages = {186--193},
doi = {10.1089/vim.2024.0015}
}
EUVIMED